文献速递免疫规划卫生政策与健康促进

疫苗短缺是欧洲相关公共卫生问题吗?欧盟疫苗接种联合行动框架下的一项调查结果

Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination.
PubMed 文献 · Vaccine · 2022-02-19

在欧洲疫苗接种联合行动(EU-JAV)框架下,对28个国家(20个EU-JAV成员国和8个其他EU/EEA国家)开展调查,收集2016至2019年疫苗短缺和断货事件、原因及应对措施。21国完成调查(应答率75%),其中19国报告至少一起短缺/断货事件,共115起,28起导致国家免疫规划变更。短缺中位持续时间5个月(范围<1个月至39个月),供应中断和全球短缺是最常见原因。

要点

  • 21个应答国家中19个报告2016至2019年至少一起疫苗短缺/断货事件,共115起。
  • 28起事件导致国家免疫规划变更,短缺中位持续时间5个月(范围<1个月至39个月)。
  • 仅约半数国家有免疫供应链改进计划或应对短缺/断货的建议或程序。

核心结论

  • 调查显示2016至2019年EU/EEA多国经历疫苗短缺/断货,需所有利益相关方协调行动、统一定义、加强报告监测系统、各国制定免疫供应链改进计划及短缺时替代疫苗或接种程序的使用建议。

研究设计与样本

  • 在欧盟疫苗接种联合行动(EU-JAV)框架下开展调查,邀请28个国家(20个EU-JAV成员国和8个其他EU/EEA国家)参与,收集2016至2019年疫苗短缺/断货信息。
  • 21个国家完成调查(应答率75%)。

主要发现

  • 21个应答国家中19个报告至少一起短缺/断货事件,共报告115起事件。
  • 115起事件中28起导致国家免疫规划变更。
  • 最常涉及的疫苗为含DT和dT的联合疫苗、乙型肝炎疫苗、甲型肝炎疫苗和BCG疫苗。
  • 短缺/断货中位持续时间5个月(范围<1个月至39个月)。
  • 供应中断和全球短缺是最常报告的原因;调查还发现其他生物制品短缺/断货(如12个国家报告白喉抗毒素短缺)。

关键数值与推荐

  • 仅约半数国家报告有免疫供应链改进计划。
  • 仅约半数国家有针对短缺/断货的建议或程序。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

National immunisation programmes require an adequate supply of vaccines to function properly but many countries, globally and in Europe, have reported vaccine shortages. A comprehensive view of vaccine shortages and stockouts in the EU/EEA is missing in the published literature. This study was conducted in the framework of the European Joint Action on Vaccination (EU-JAV). Twenty-eight countries, including 20 EU-JAV consortium member states and an additional 8 EU/EEA countries, were invited to participate in a survey aimed at collecting information on vaccine shortages and stock-outs experienced from 2016 to 2019, their main causes, actions taken, and other aspects of vaccine supply. Twenty-one countries completed the survey (response rate 75%), of which 19 reported at least one shortage/stock-out event. Overall, 115 events were reported, 28 of which led to a change in the national immunisation programme. The most frequently involved vaccines were DT- and dT-containing combination vaccines, hepatitis B, hepatitis A, and BCG vaccines. The median duration of shortages/stock-outs was five months (range <1 month-39 months). Interruption in supply and global shortage were the most frequently indicated causes. Only about half of countries reported having an immunization supply chain improvement plan. Similarly, only about half of countries had recommendations or procedures in place to address shortages/stockouts. The survey also identified the occurrence of shortages/stockouts of other biological products (e.g. diphtheria antitoxin in 12 countries). Public health strategies to assure a stable and adequate vaccine supply for immunization programmes require coordinated actions from all stakeholders, harmonized definitions, strengthening of reporting and monitoring systems, the presence of an immunization supply chain improvement plan in all countries, and procedures or recommendations in place regarding the use of alternative vaccines or vaccination schedules in case of shortages/stockouts.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Filia A, Rota MC, Grossi A, et al. Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination. Vaccine. 2022. PMID: 35190211. doi:10.1016/j.vaccine.2022.02.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。